Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017;90(3):256-261.
doi: 10.15386/cjmed-712. Epub 2017 Jul 15.

Circulating tumor cells in thyroid carcinoma - the prognostic role of this biomarker. Review of the literature

Iulian Claudiu Bădulescu  1 , Elena Bărbuş  1 , Doina Piciu  1
Affiliations
Review

Circulating tumor cells in thyroid carcinoma - the prognostic role of this biomarker. Review of the literature

Iulian Claudiu Bădulescu et al. Clujul Med. 2017.

Abstract

Thyroid cancer is a disease with a good prognosis and high survival rates, but having a marked growth of incidence all over the world in the last years. This fact requires special attention of researchers for understanding the behavior of this disease and to establish a correct therapy. Analysis of circulating tumor cells in patients with different malignancies is nowadays a new and exciting research tool, which can improve the diagnosis and prevent the metastatic disease. In the case of thyroid carcinoma there are few studies which explore these biomarkers and investigate the prognostic significance of circulating tumor cells. With this review we seek to emphasize the role of these cells to better understand the mechanisms of invasion or metastasis and to establish a new research base to treat aggressive forms of this type of cancer. Most of the included studies demonstrate the efficacy of these markers for diagnosis and follow up.

Keywords: circulating tumor cells; prognosis; thyroid carcinoma.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Thyroid cancer incidence at the “Ion Chiricuta” Oncology Institute (IOCN), 1970–2014 [1].
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Piciu D. Imagistica de fuziune PET/CT in oncologie. [Fusion PET/CT imaging in oncology]. Cluj-Napoca: Editura Medicala Universitara „Iuliu Hatieganu”; 2016. pp. 207–211.
    1. International Agency for Research in Cancer. GLOBOCAN 2012. Estimated Cancer Incidence, Mortality and Prevalence in 2012. Online Analysis. Available from: http://globocan.iarc.fr/Pages/online.aspx.
    1. Zane M, Agostini M, Enzo MV, Casal Ide E, Del Bianco P, Torresan F, et al. Circulating cell-free DNA, SLC5A8 and SLC26A4 hypermethylation, BRAF(V600E): A non-invasive tool panel for early detection of thyroid cancer. Biomed Pharmacother. 2013;67(8):723–730. - PubMed
    1. Chia SY, Milas M, Reddy SK, Siperstein A, Skugor M, Brainard J, et al. Thyroid-stimulating hormone receptor messenger ribonucleic acid measurement in blood as a marker for circulating thyroid cancer cells and its role in the preoperative diagnosis of thyroid cancer. J Clin Endocrinol Metab. 2007;92(2):468–475. - PubMed
    1. Cebotaru CL, Olteanu ED, Antone NZ, Buiga R, Nagy V. Circulating tumour cells in germ cells tumours: are those biomarkers of real prognostic value? A review. Clujul Med. 2016;89(2):203–211. - PMC - PubMed

LinkOut - more resources